Literature DB >> 626945

Herpes zoster and varicella infections in children with Hodgkin's disease: an analysis of contributing factors.

F Reboul, S S Donaldson, H S Kaplan.   

Abstract

181 children with Hodgkin's disease were analyzed with respect to the occurrence of herpes zoster and varicella (HZ-V) infections, possible contributing factors, and prognostic significance. The overall frequency of HZ-V was 34.8%. The occurrence in stage I was significantly lower than in other stages. Previous splenectomy was not found to increase significantly the risk of infection. High-risk patients were those receiving extensive radiotherapy plus combination chemotherapy; 56% developed HZ-V infections in this group. The frequency with extensive field radiotherapy alone was 23.8%. 80% of infections occurred during the first year after completion of treatment. Their occurrence was not a poor prognostic sign in terms of relapse or fatality, even when occurring late. The high frequency of disseminated infection (27%) with its subsequent morbidity should lead toward a better understanding of the immunologic deficiencies in these patients and the possible role of prophylactic measures, in patients undergoing extensive radiotherapy in combination with multiagent chemotherapy.

Entities:  

Mesh:

Year:  1978        PMID: 626945     DOI: 10.1002/1097-0142(197801)41:1<95::aid-cncr2820410114>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Pharmacologic management of herpes zoster and postherpetic neuralgia.

Authors:  F S Mamdani
Journal:  Can Fam Physician       Date:  1994-02       Impact factor: 3.275

2.  Management of childhood lymphomas - Hodgkin's disease and non-Hodgkin's lymphomas.

Authors:  C C Patel
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

3.  Effect of 5-iodo-5'-amino-2',5'-dideoxyuridine on varicella-zoster virus in vitro.

Authors:  J P Iltis; T S Lin; W H Prusoff; F Rapp
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

4.  Inhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virus.

Authors:  H Machida; A Kuninaka; H Yoshino
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

5.  Increased risk of varicella-zoster virus infection in patients with breast cancer after adjuvant radiotherapy: A population-based cohort study.

Authors:  Yo-Liang Lai; Yuan-Chih Su; Chia-Hung Kao; Ji-An Liang
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

6.  Radiotherapy combined with chemotherapy increases the risk of herpes zoster in patients with gynecological cancers: a nationwide cohort study.

Authors:  Peng Yi Lee; Jung Nien Lai; Shang Wen Chen; Ying Chun Lin; Lu Ting Chiu; Yu Ting Wei
Journal:  J Gynecol Oncol       Date:  2020-12-02       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.